Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics.

Journal: Cell

Published: 2020-06-18

DOI: 10.1016/j.cell.2020.05.028

Affiliations: 6

Authors: 12

Go to article
Institutions Share
Hangzhou Research Institute, TIPC CAS, China 0.22
Guangdong Provincial Key Laboratory of Tumor Immunotherapy, SMU, China 0.19
School of Basic Medical Sciences, SMU, China 0.19
The Eighth Affiliated Hospital, SYSU, China 0.14
UCSF Cardiovascular Research Institute (CVRI), United States of America (USA) 0.13
UCSF Department of Pharmaceutical Chemistry, United States of America (USA) 0.13

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER